Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum

被引:47
作者
Albrethsen, Jakob [1 ]
Bogebo, Rikke
Olsen, Jesper
Raskov, Hans
Gammeltoft, Steen
机构
[1] Glostrup Cty Hosp, Dept Clin Biochem, DK-2600 Glostrup, Denmark
[2] Glostrup Cty Hosp, Dept Gastrosurg, DK-2600 Glostrup, Denmark
[3] Colotech Ltd, Copenhagen, Denmark
关键词
mass spectrometry; proteomics; surface-enhanced laser desorption-ionization time-of-flight (SELDI-TOF); serum protein peaks;
D O I
10.1515/CCLM.2006.228
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Surface-enhanced laser desorption-ionization time-of-flight (SELDI-TOF) mass spectrometry of human serum is a potential diagnostic tool in human diseases. In the present study, the preanalytical and analytical variation of SELDI-TOF mass spectrometry of serum was assessed in healthy individuals. Methods: Serum and plasma were obtained from healthy human individuals. Protein peaks in human serum and plasma were determined by SELDI-TOF mass spectrometry. Results: The protein peaks in serum in healthy individuals showed no variation with gender, age, fasting, or diurnal rhythm. The intensity of protein peaks changed significantly during clotting of serum from 30 to 60 min, followed by smaller changes from 60 to 120 min. The intensity of protein peaks changed after 60-min storage of serum at room temperature, whereas no changes were observed for storage on ice. The number of reproducible protein peaks in serum was determined on WCX2, SAX2, and IMAC30 arrays as 29, 34, and 36, respectively. The average coefficient of variation (CV) of the mass value of protein peaks was 0.03%. The intra-assay CV of peak intensity on IMAC30 arrays was 16% (10% -36%, n=8) for 36 peaks, inter-assay CV was 18% (6% -34%, n=4) for 16 peaks, and inter-individual CV was 38% (16% -56%, n=16) for 20 peaks. Conclusions: The pre-analytical and analytical conditions of SELDI-TOF mass spectrometry of serum have a significant impact on the protein peaks, with the number of peaks low and the assay variation high. Consequently, SELDI-TOF mass spectrometry of serum needs further evaluation before application in clinical diagnostics.
引用
收藏
页码:1243 / 1252
页数:10
相关论文
共 36 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
ADEYEMI EO, 1988, J CLIN LAB IMMUNOL, V27, P1
[3]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[4]   Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling [J].
Aivado, M ;
Spentzos, D ;
Alterovitz, G ;
Otu, HH ;
Grall, F ;
Giagounidis, AAN ;
Wells, M ;
Cho, JY ;
Germing, U ;
Czibere, A ;
Prall, WC ;
Porter, C ;
Ramoni, MF ;
Libermann, TA .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (02) :133-140
[5]   ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke [J].
Allard, L ;
Lescuyer, P ;
Burgess, J ;
Leung, KY ;
Ward, M ;
Walter, N ;
Burkhard, PR ;
Corthals, G ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2004, 4 (08) :2242-2251
[6]   The human plasma proteome - A nonredundant list developed by combination of four separate sources [J].
Anderson, NL ;
Polanski, M ;
Pieper, R ;
Gatlin, T ;
Tirumalai, RS ;
Conrads, TP ;
Veenstra, TD ;
Adkins, JN ;
Pounds, JG ;
Fagan, R ;
Lobley, A .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :311-326
[7]   Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry [J].
Banks, RE ;
Stanley, AJ ;
Cairns, DA ;
Barrett, JH ;
Clarke, P ;
Thompson, D ;
Selby, PJ .
CLINICAL CHEMISTRY, 2005, 51 (09) :1637-1649
[8]   Proteomic profiling of pancreatic cancer for biomarker discovery [J].
Chen, R ;
Pan, S ;
Brentnall, TA ;
Aebersold, R .
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (04) :523-533
[9]   Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population [J].
Chen, YD ;
Zheng, S ;
Yu, JK ;
Hu, X .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8380-8385
[10]  
Diamandis EP, 2005, CLIN CANCER RES, V11, P963